These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 9337957)

  • 1. Plasma noradrenaline response to electroconvulsive therapy in depressive illness.
    Kelly CB; Cooper SJ
    Br J Psychiatry; 1997 Aug; 171():182-6. PubMed ID: 9337957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adrenergic receptors in depression. Effects of electroconvulsive therapy.
    Cooper SJ; Kelly JG; King DJ
    Br J Psychiatry; 1985 Jul; 147():23-9. PubMed ID: 2998528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma norepinephrine response to a cold pressor test in subtypes of depressive illness.
    Kelly CB; Cooper SJ
    Psychiatry Res; 1998 Oct; 81(1):39-50. PubMed ID: 9829649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of electroconvulsive therapy on peripheral adrenoceptors, plasma, noradrenaline, MHPG and cortisol in depressed patients.
    Werstiuk ES; Coote M; Griffith L; Shannon H; Steiner M
    Br J Psychiatry; 1996 Dec; 169(6):758-65. PubMed ID: 8968635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences and variability in plasma noradrenaline between depressive and anxiety disorders.
    Kelly CB; Cooper SJ
    J Psychopharmacol; 1998; 12(2):161-7. PubMed ID: 9694029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma pattern of adrenocorticotropin and cortisol during electroconvulsive therapy in patients with major depressive illness.
    Apéria B; Thorén M; Zettergren M; Wetterberg L
    Acta Psychiatr Scand; 1984 Oct; 70(4):361-9. PubMed ID: 6093435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DSM melancholic features are unreliable predictors of ECT response: a CORE publication.
    Fink M; Rush AJ; Knapp R; Rasmussen K; Mueller M; Rummans TA; O'Connor K; Husain M; Biggs M; Bailine S; Kellner CH;
    J ECT; 2007 Sep; 23(3):139-46. PubMed ID: 17804986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electroconvulsive therapy-induced cortisol release after dexamethasone in depression.
    Swartz CM
    Neuropsychobiology; 1992; 25(3):130-3. PubMed ID: 1407478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alteration of immune markers in a group of melancholic depressed patients and their response to electroconvulsive therapy.
    Rush G; O'Donovan A; Nagle L; Conway C; McCrohan A; O'Farrelly C; Lucey JV; Malone KM
    J Affect Disord; 2016 Nov; 205():60-68. PubMed ID: 27414954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute effects of single and repeated electroconvulsive therapy on plasma catecholamines and blood pressure in major depressive disorder.
    Mann JJ; Manevitz AZ; Chen JS; Johnson KS; Adelsheimer EF; Azima-Heller R; Massina A; Wilner PJ
    Psychiatry Res; 1990 Nov; 34(2):127-37. PubMed ID: 2287647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of electroconvulsive therapy on neuropsychological function and circulating levels of ACTH, cortisol, prolactin, and TSH in patients with major depressive illness.
    Apéria B; Bergman H; Engelbrektson K; Thorén M; Wetterberg L
    Acta Psychiatr Scand; 1985 Dec; 72(6):536-41. PubMed ID: 3002132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hormone pattern and post-treatment attitudes in patients with major depressive disorder given electroconvulsive therapy.
    Apéria B
    Acta Psychiatr Scand; 1986 Mar; 73(3):271-4. PubMed ID: 3012951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac implications of increased arterial entry and reversible 24-h central and peripheral norepinephrine levels in melancholia.
    Gold PW; Wong ML; Goldstein DS; Gold HK; Ronsaville DS; Esler M; Alesci S; Masood A; Licinio J; Geracioti TD; Perini G; DeBellis MD; Holmes C; Vgontzas AN; Charney DS; Chrousos GP; McCann SM; Kling MA
    Proc Natl Acad Sci U S A; 2005 Jun; 102(23):8303-8. PubMed ID: 15919819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electroconvulsive therapy and plasma prostaglandin E2 metabolite in major depressive disorder.
    Mathe AA; Bergman P; Aperia B; Wetterberg L
    Prog Neuropsychopharmacol Biol Psychiatry; 1987; 11(6):701-7. PubMed ID: 2830639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma noradrenaline response to a cognitive stressor in subtypes of depressive illness.
    Cooper SJ; Kelly CB
    Hum Psychopharmacol; 2000 Jun; 15(4):265-274. PubMed ID: 12404321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variation of plasma cortisol levels in patients with depression after treatment with bilateral electroconvulsive therapy.
    Burgese DF; Bassitt DP
    Trends Psychiatry Psychother; 2015; 37(1):27-36. PubMed ID: 25860564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serial dexamethasone suppression tests and plasma dexamethasone levels. Effects of clinical response to electroconvulsive therapy in major depression.
    Devanand DP; Sackeim HA; Lo ES; Cooper T; Huttinot G; Prudic J; Ross F
    Arch Gen Psychiatry; 1991 Jun; 48(6):525-33. PubMed ID: 2039336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of ECT on the neuroendocrine response to apomorphine in severely depressed patients.
    Christie JE; Whalley LJ; Brown NS; Dick H
    Br J Psychiatry; 1982 Mar; 140():268-73. PubMed ID: 6807386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of ECT on plasma cyclic nucleotides: a simulated ECT controlled study in melancholic patients.
    Lykouras L; Markianos M; Hatzimanolis J; Stefanis C
    Eur Arch Psychiatry Neurol Sci; 1990; 239(6):343-6. PubMed ID: 2168317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 5-Hydroxy-indolacetic-acid (5-HIAA) serum levels in depressive patients and ECT.
    Hofmann P; Loimer N; Chaudhry HR; Pfersmann D; Schmid R; Wieselmann G
    J Psychiatr Res; 1996; 30(3):209-16. PubMed ID: 8884659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.